Search research articles
Contact Us
Filters
Showing results (381-390 of 455) with videos related to
Page
of 46
Sort By:
European Journal of Endocrinology
|
July 25, 2024
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial
Laura S Hansen, Lærke S Gasbjerg, Andreas Brønden, et al.
Endocrine Connections
|
November 30, 2020
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
David S Mathiesen, Jonatan I Bagger, Katrine B Hansen, et al.
European Journal of Preventive Cardiology
|
January 8, 2026
Effects of empagliflozin in patients at risk of heart failure: the Empire Prevent Metabolic Trial
Camilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
Diabetologia
|
June 4, 2014
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Nicolai J Wewer Albrechtsen, Bolette Hartmann, Simon Veedfald, et al.
Diabetes
|
January 25, 2020
Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis
Malte P Suppli, Jonatan I Bagger, Asger Lund, et al.
Diabetologia
|
May 13, 2020
The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial
Caroline T B Juel, Asger Lund, Maria M Andersen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 21, 2020
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals
Lærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
The Lancet. Diabetes & Endocrinology
|
March 6, 2020
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Nicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Diabetologia
|
March 28, 2024
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial
Ditte S Kornum, Davide Bertoli, Huda Kufaishi, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial
Signe Foghsgaard, Louise Vedtofte, Emilie S Andersen, et al.
Page
of 46
Search research articles
Search
Showing results (381-390 of 455) with videos related to
Sort By:
Page
of 46
European Journal of Endocrinology
|
July 25, 2024
The role of glucagon-like peptide 1 in the postprandial effects of metformin in type 2 diabetes: a randomized crossover trial
Laura S Hansen, Lærke S Gasbjerg, Andreas Brønden, et al.
Endocrine Connections
|
November 30, 2020
No detectable effect of a type 2 diabetes-associated TCF7L2 genotype on the incretin effect
David S Mathiesen, Jonatan I Bagger, Katrine B Hansen, et al.
European Journal of Preventive Cardiology
|
January 8, 2026
Effects of empagliflozin in patients at risk of heart failure: the Empire Prevent Metabolic Trial
Camilla Fuchs Andersen, Julie Hempel Larsen, Massar Omar, et al.
Diabetologia
|
June 4, 2014
Hyperglucagonaemia analysed by glucagon sandwich ELISA: nonspecific interference or truly elevated levels?
Nicolai J Wewer Albrechtsen, Bolette Hartmann, Simon Veedfald, et al.
Diabetes
|
January 25, 2020
Glucagon Resistance at the Level of Amino Acid Turnover in Obese Subjects With Hepatic Steatosis
Malte P Suppli, Jonatan I Bagger, Asger Lund, et al.
Diabetologia
|
May 13, 2020
The GLP-1 receptor agonist lixisenatide reduces postprandial glucose in patients with diabetes secondary to total pancreatectomy: a randomised, placebo-controlled, double-blinded crossover trial
Caroline T B Juel, Asger Lund, Maria M Andersen, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 21, 2020
GIP and GLP-1 Receptor Antagonism During a Meal in Healthy Individuals
Lærke S Gasbjerg, Mads M Helsted, Bolette Hartmann, et al.
The Lancet. Diabetes & Endocrinology
|
March 6, 2020
Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial
Nicklas J Johansen, Thomas F Dejgaard, Asger Lund, et al.
Diabetologia
|
March 28, 2024
Transcutaneous vagal nerve stimulation for treating gastrointestinal symptoms in individuals with diabetes: a randomised, double-blind, sham-controlled, multicentre trial
Ditte S Kornum, Davide Bertoli, Huda Kufaishi, et al.
Diabetes, Obesity & Metabolism
|
October 17, 2023
Liraglutide treatment for the prevention of glucose tolerance deterioration in women with prior gestational diabetes mellitus: A 52-week randomized controlled clinical trial
Signe Foghsgaard, Louise Vedtofte, Emilie S Andersen, et al.
Page
of 46